Header Logo

Connection

ARGUN AKCAKANAT to Neoplasms

Back to Details
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Neoplasms.
ARGUN AKCAKANAT
Connection Strength
0.136
Neoplasms
  1. Targeting PI3K/mTOR signaling in cancer. Cancer Res. 2011 Dec 15; 71(24):7351-9.
    View in: PubMed
    Score: 0.062
  2. SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. J Natl Cancer Inst. 2015 Mar; 107(3).
    View in: PubMed
    Score: 0.020
  3. Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors. Oncotarget. 2014 Sep 30; 5(18):8544-57.
    View in: PubMed
    Score: 0.019
  4. Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial. Clin Cancer Res. 2013 Oct 01; 19(19):5474-84.
    View in: PubMed
    Score: 0.018
  5. Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg Oncol Clin N Am. 2013 Oct; 22(4):641-64.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.